Limited Competition for Continuation of the Prospective Study of Chronic Kidney Disease in Children Clinical Coordinating Centers (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-DK-22-504 from the NIH Guide for Grants and Contracts. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), in collaboration with the National Heart, Lung and Blood Institute (NHLBI) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), invites applications for a limited competition for the two Clinical Coordinating Centers (CCCs) already involved in The Chronic Kidney Disease in Children Study (CKiD) Consortium. The clinical centers will continue to evaluate enrolled participants, recruit new participants, and continue to work t...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 15, 2022 Category: Research Source Type: funding
Chronic Kidney Disease in Children Central Biochemistry Laboratory (U24 Clinical Trial Not Allowed)
Funding Opportunity RFA-DK-22-010 from the NIH Guide for Grants and Contracts. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), in collaboration with the National Heart, Lung and Blood Institute (NHLBI) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), invites applications for the Central Biochemistry Laboratory (CBL) for the Chronic Kidney Disease in Children Study (CKiD) Consortium. The CBL will work cooperatively with the existing Clinical Coordinating Centers (CCCs) and the Data Coordinating Center (DCC) of the study as a consortium. (Source...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 15, 2022 Category: Research Source Type: funding
Limited Competition for Continuation of the Prospective Study of Chronic Kidney Disease in Children Data Coordinating Center (U24 Clinical Trial Not Allowed)
Funding Opportunity RFA-DK-22-505 from the NIH Guide for Grants and Contracts. The NIDDK, in collaboration with the NHLBI and NICHD, invites an application for a limited competition for the Data Coordinating Center (DCC) already involved in The Chronic Kidney Disease in Children Study (CKiD) Consortium. The DCC will work cooperatively with the existing Clinical Coordinating Centers (CCCs) and Central Biochemistry Laboratory (CBL) of the study as a consortium. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 15, 2022 Category: Research Source Type: funding
Modern Equipment for Shared-use Biomedical Research Facilities: Advancing Research-Related Operations (R24 Clinical Trials Not Allowed)
Funding Opportunity PAR-22-190 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites qualified academic or research institutions to apply for funding support to purchase advanced equipment that will enhance and modernize research-supporting operations of biomedical research facilities. Targeted are laboratory research core facilities, animal research facilities, and other similar shared-use research spaces. The goal of this FOA is to strengthen research-auxiliary activities of biomedical research facilities and to enhance the efficiency of their operations. The FOA does not sup...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 11, 2022 Category: Research Source Type: funding
Notice of Intent to Publish a Funding Opportunity Announcement for Environmental influences on Child Health Outcomes (ECHO) Laboratory Core (U24) Clinical Trial Not Allowed
Notice NOT-OD-22-170 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 6, 2022 Category: Research Source Type: funding
New Approaches for Incorporating Genetic Diversity into Toxicity Testing (R43/R44 Clinical Trial Not Allowed)
Funding Opportunity RFA-ES-22-006 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) supports Phase I (R43), Phase II (R44), Direct to Phase II (R44), and Fast Track (R44) Small Business Innovative Research (SBIR) grant applications from small businesses concerns (SBCs) to develop resources and approaches, including panels of cells or model organisms, that reflect the variability in human populations in chemical toxicity testing . Current toxicology testing is often limited to studies conducted in a small number of laboratory rodent strains, which can fail to identify clinically rel...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 30, 2022 Category: Research Source Type: funding
NIH All About Grants Podcast: Animal Welfare Assurances
Dr. Jane Na, Director of Division of Assurances, OLAW, NIH
Institutions receiving funds from Public Health Service (PHS) agencies such as NIH must conduct research in accordance with the PHS Policy on Humane Care and Use of Laboratory Animals. As part of this process, institutions must have an approved animal welfare assurance on file with the NIH Office of Laboratory Animal Welfare (OLAW) in order to receive PHS support on activities involving animals. But what exactly does this process entail?
This NIH All About Grants podcast episode delves into what you should consider when working with OLAW in obtaining an animal welf...
Source: NIH Extramural Nexus - June 29, 2022 Category: Research Authors: NIH Staff Tags: New Resources Animal Welfare Assurances podcast Source Type: funding
Partnerships for Innovation (PFI)
Full Proposal Deadline Date: July 13, 2022 Program Guidelines: NSF 19-506The Partnerships for Innovation (PFI) Program within the Division of Industrial Innovation and Partnerships (IIP) offers researchers from all disciplines of science and engineering funded by NSF the opportunity to perform translational research and technology development, catalyze partnerships and accelerate the transition of discoveries from the laboratory to the marketplace for societal benefit.
PFI has five broad goals, as set forth by the American Innovation and Competitiveness ...More at https://beta.nsf.gov/programid/504790This is an NSF Upcomi...
Source: NSF Upcoming Due Dates - June 13, 2022 Category: Science Source Type: funding
NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed)
Funding Opportunity PAR-22-188 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites grant applications for the Research Specialist Award (R50) in any area of NCI-funded cancer research. This FOA is specifically for laboratory-based scientists.The Research Specialist Award is designed to encourage the development of stable research career opportunities for exceptional scientists who want to continue to pursue research within the context of an existing NCI-funded basic, translational, clinical, or population science cancer research program, but not serve as independent investiga...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 25, 2022 Category: Research Source Type: funding
NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed)
Funding Opportunity PAR-22-187 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites grant applications for the Research Specialist Award (R50) in any area of NCI-funded cancer research. This FOA is specifically for laboratory-based scientists.The Research Specialist Award is designed to encourage the development of stable research career opportunities for exceptional scientists who want to continue to pursue research within the context of an existing NCI-funded basic, translational, clinical, or population science cancer research program, but not serve as independent investiga...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 25, 2022 Category: Research Source Type: funding
Maximizing Investigators Research Award (MIRA) for Early Stage Investigators (R35 - Clinical Trial Optional)
Funding Opportunity PAR-22-180 from the NIH Guide for Grants and Contracts. The Maximizing Investigators' Research Award (MIRA) provides support for the program of research in an investigator's laboratory that is within the mission of NIGMS. The goal of MIRA is to increase the efficiency and efficacy of NIGMS funding. It is anticipated that this program will: Increase the stability of funding for NIGMS-supported investigators, which could enhance their ability to take on ambitious scientific projects and approach problems more creatively; Increase flexibility for investigators to follow important new research directions...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 24, 2022 Category: Research Source Type: funding
Maximizing Investigators' Research Award (R35 - Clinical Trial Optional)
Funding Opportunity PAR-22-180 from the NIH Guide for Grants and Contracts. The Maximizing Investigators' Research Award (MIRA) provides support for the program of research in an investigator's laboratory that is within the mission of NIGMS. The goal of MIRA is to increase the efficiency and efficacy of NIGMS funding. It is anticipated that this program will: Increase the stability of funding for NIGMS-supported investigators, which could enhance their ability to take on ambitious scientific projects and approach problems more creatively; Increase flexibility for investigators to follow important new research directions...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 24, 2022 Category: Research Source Type: funding
Infrastructure Development Training Programs for Critical HIV Research at Low-and Middle-Income Country Institutions (G11 Clinical Trials Not Allowed)
Funding Opportunity PAR-22-153 from the NIH Guide for Grants and Contracts. The overall goal of the Fogarty International Center (FIC) HIV Research Training Program is to strengthen the scientific capacity of institutions in low- and middle-income countries (LMICs) to conduct HIV research on the evolving HIV epidemic in their countries.This FOA encourages collaborative applications from U.S. and LMIC institutions to support training to achieve technical, administration and financial management expertise required for one of the six research infrastructure functions considered critical to a successful high quality researc...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 21, 2022 Category: Research Source Type: funding
Reducing Administrative Burden in Laboratory Animal Research: What Have We Done Recently and What ’s Coming…
Pat Brown, Director, NIH Office of Laboratory Animal Welfare
The 21st Century Cures Act called for NIH to collaborate with the U.S. Department of Agriculture (USDA) and Food and Drug Administration (FDA) to reduce administrative burdens associated with laboratory animal research programs, while maintaining high standards of animal welfare as well as the integrity and credibility of the research. We jointly released a final report in 2019 outlining steps to accomplish this goal, and have since worked together to implement many of the recommendations. We wanted to take this opportunity today to share some of NIH’s progress...
Source: NIH Extramural Nexus - April 20, 2022 Category: Research Authors: Mike Lauer Tags: blog Open Mike Administrative Burden Animal Welfare RFI Source Type: funding
NSF Innovation Corps Hubs Program (I-Corps  Hubs)
Full Proposal Deadline Date: May 11, 2022 I-Corps Hub awards (Track 1 and 2) and New Partner Institution Supplements Program Guidelines: NSF 22-566The National Science Foundation (NSF) seeks to further develop and nurture a national innovation ecosystem that guides the output of scientific discoveries closer to the development of technologies, products, processes, and services that benefit society. The goal of the NSF Innovation Corps (I-Corps) Program, created in 2011 by NSF, is to reduce the time and risk associated with translating promising ideas and technologies from the laboratory to the marketplace, to increase the ...
Source: NSF Upcoming Due Dates - April 11, 2022 Category: Science Source Type: funding
